Blue Horseshoe Stocks: ENPH Review & More

Aytu BioScience, Inc. AYTU

We’ve done our best this week in reminding readers that our interest in AYTU was not a drill. Beginning from our initial alert in last Wednesday’s premarket report, the stock was exhibiting all the signs of a recovery play.

Yesterday we reiterated our interest for the second time this week, mentioning how the stock had already come a considerable distance from our observed  low of .4118, and that it had picked up momentum on Monday, and that more gains could be in store.

We were right on the money as the stock extended its recent gains yesterday running to a new high of .76, which represents a five day swing of 85%


Enphase Energy, Inc. ENPH

Recently, we have had quite a few plays we’ve signaled within the past couple of months, exhibit really convincing, sustained uptrends, and ENPH is another one to put in that category.

While our most recent mention of the stock came on March 19th, in the midst of the current run as a reminder, our initial call came on February 28th.  On that day, the stock saw a low of 3.07 and hasn’t looked back since.

Yesterday, ENPH surged to a new high of 5.58, marking a respectable one month run of 82% during which time volume has also been greatly increased.



Fresh Options Ideas –
Both of the following are looking good today with untraded-upon earnings beats, so we’ve got a pair of fresh ideas to share this morning:

Lululemon Athletica Inc. LULU Weekly $83-85 Calls
Blackberry Ltd. BB Weekly $12.50 & $13 Calls


Extended Watchlist:
TOPS, ANW, IDXG, LHO, MARA

Blue Horseshoe Stocks: RXMD Recap

Nxt-ID, Inc. NXTD

We most recently mentioned NXTD a couple of weeks ago on February 12th, following a long period of consolidation off of the massive run we observed back in December. The stock seemed to be settling down at a bottom, and indeed, it reached its low of 2.00 the very next day.

After a bit of sideways trading NXTD has awakened in a big way on the heels of a key development coming over the newswires (see snippet below). Already in the premarket, it has risen by 100% since our alert, hitting 4.00 in early trading.

In addition to the stock itself, we’re also going to place a couple of contracts in the NXTD options chain in watch, the NXTD 03/16 $2.50 & $5 Calls.

Discover Financial Services and FitPay, Inc., a wholly owned subsidiary of NXT-ID, Inc., today announced a network services agreement to allow devices that are integrated with the FitPay Payment Platform[TM] to provision tokenized payment credentials through Discover® Digital Exchange (DDX). The agreement enables Discover cardholders, along with alliance partner cards, to easily make contactless payment transactions at retail locations with wearable or Internet of Things (IoT) devices that include payment capabilities powered by FitPay[TM] (>>View Full PR)


Progressive Care, Inc. RXMD

We initially flagged RXMD in Thursday’s premarket report after noticing the amount of momentum that had been building up in the stock recently. It managed to finish out the week sustaining that momentum and continuing to head into blue skies, setting a new 52-week high with each uptick.

From Thursday morning’s low of .0663, the stock attained a high of .0979 which workes out to a two day swing of 48% and stand as the highest PPS recorded since 2013.



Fresh Options Idea:
Target Corp. TGT Weekly $75-76.50 Calls


Extended Watchlist:
BPMX, CTRV, GTT, HRG, SPB, IDXG, FINL, ATNM(Bottom-Watch)

Blue Horseshoe Stocks: TEUM Update & More

Pareteum Corp. TEUM

The last time we mentioned TEUM was December 8th, shortly after which time the stock was trading for as little as .661. At the time the company had no involvement in the trendy cryptocurrency space.

Flash forward to this week, and an announcement that the company is adding blockchain capability for cryptocurrency support on its global cloud billing platform has the stock soaring to new highs.

TEUM hit 3.15 yesterday, which marks an increase of 377% in less than three weeks’ time. Volume for the day was on the order of roughly five times the monthly average.

Bitcoin itself has been making a nice rebound after the pullback which followed its big run to nearly $20K, and there is no reason to suspect that the push toward blockchain related technologies, both cryptocurrency and otherwise, is just a passing fad.


INSYS Therapeutics, Inc. INSY – Options Recap

We made our interest in the INSY 01/19 $8 & $9 Calls known yesterday morning, and it barely took any time at all for our ideas to come to fruition.

As we were mentioning yesterday, the company recently initiated Phase II trials of its synthetic Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy, and the FDA granted Fast Track status to the ‘drug’ for the treatment of a rare genetic disorder (Prader-Willi).

This news allowed for some very nice moves in our designated contracts. The $8 Calls ran from .35-1.00 for a gain of 186%, while the $9’s traded up from .20-.55, trending up 175% on the day.


Ampio Pharmaceuticals, Inc. AMPE

We also want to swing back to remind our readers of last week’s alert on AMPE. We tagged this play seven days ago (four trading days), and saw it trading for as little as 2.57. As of yesterday’s high of 3.55, the stock had thus far risen by 38%

The stock’s peak PPS represented a new annual high, so we’ll be interested to see how the stock performs in blue skies.


Extended Watchlist:
OTIV, FH, NETE, LFIN, GROW, IDXG, WATT, ATNM